Evidence map›Paper›PMID 35423640›Full record

ArticleRSC advances2021

A network pharmacology study on main chemical compounds from

Ki Kwang Oh, Md Adnan, Inseok Ju, Dong Ha Cho

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Network Pharmacology Study onInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ki Kwang OhDepartment of Bio-Health Convergence, College of Biomedical Science, Kangwon National University Chuncheon 24341 Korea chodh@kangwon.ac.kr nivirna07@kangwon.ac.kr mdadnan1991.pharma@gmail.com +82-33-250-6475.
Md AdnanDepartment of Bio-Health Convergence, College of Biomedical Science, Kangwon National University Chuncheon 24341 Korea chodh@kangwon.ac.kr nivirna07@kangwon.ac.kr mdadnan1991.pharma@gmail.com +82-33-250-6475.ORCID https://orcid.org/0000-0002-1330-2169
Inseok JuDepartment of Bio-Health Technology, College of Biomedical Science, Kangwon National University Chuncheon 24341 Korea sherpa7@kangwon.ac.kr.
Dong Ha ChoDepartment of Bio-Health Convergence, College of Biomedical Science, Kangwon National University Chuncheon 24341 Korea chodh@kangwon.ac.kr nivirna07@kangwon.ac.kr mdadnan1991.pharma@gmail.com +82-33-250-6475.ORCID https://orcid.org/0000-0003-3597-3235
Kangwon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35423640
PMCPMC8695834
OpenAlexW3136601682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.